EQ Overview
Upcoming Projects (EQ)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (EQ)
-
Discussing Equillium's EQUALISE Type B Phase 1b Study of itolizumab in Active Proliferative Lupus Nephritis
Ticker: EQ
Executed On: Apr 01, 2024 at 01:00 PM EDT -
Examining the potential of Equillium's Itolizumab in treating lupus nephritis
Ticker: EQ
Executed On: Oct 25, 2022 at 12:00 PM EDT
Expired Projects (EQ)
-
Examining the potential of Equillium’s EQ001 (itolizumab) in Acute Graft Versus Host Disease
Ticker: EQ
Execute By: Jul 31, 2020
Upcoming & Overdue Catalysts (EQ)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (EQ)
-
Incyte (INCY) Posts Results of Phase 3 Study of Itacitinib in Patients with Treatment-Naïve Acute Graft-Versus-Host Disease
Tickers: INCY, EQ
Occurred on: Jan 02, 2020
Strategic Initiatives (EQ)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
